SCHEMBL10069714

SCHEMBL10069714

Cc1ncccc1OC(=O)N1CCC(c2nc(-c3cccc(Cl)c3)n[nH]2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
GPR142 Q7Z601 2/20 0.42
KDM5A P29375 1/20 0.41
KCNH2 Q12809 1/20 0.40
P2RY12 Q9H244 1/20 0.40
TLR9 Q9NR96 2/20 0.39
TLR8 Q9NR97 2/20 0.39
TLR7 Q9NYK1 2/20 0.39
GRM5 P41594 2/20 0.39
TRPA1 O75762 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
USP30 Q70CQ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10070552 0.90 HTR2B (0.43) HSD11B1HRH3KDM5AP2RY12TLR9
SCHEMBL10070536 0.90 CPT1A (0.46) HSD11B1GPR142P2RY12TLR9TLR8
SCHEMBL10070539 0.89 P2RY12 (0.47) HSD11B1P2RY12USP30GPR119HTR2B
SCHEMBL10070106 0.88 CPT1A (0.46) HSD11B1P2RY12TLR9TLR8TLR7
SCHEMBL10070095 0.87 CPT2 (0.49) HSD11B1GPR142P2RY12TRPA1NPSR1
SCHEMBL10070550 0.86 CPT1A (0.40) HSD11B1KDM5AP2RY12TLR9TLR8
SCHEMBL10070076 0.86 KIT (0.44) HSD11B1KCNH2P2RY12TLR9TLR8
SCHEMBL10069537 0.84 HSD11B1 (0.43) HSD11B1HRH3GPR142KDM5AKCNH2
SCHEMBL10070512 0.84 HSD11B1 (0.42) HSD11B1MEN1ALDH1A1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL1653157 0.83 HSD11B1 (0.42) HSD11B1MEN1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308869-B1 AZOLE COMPOUND ASTELLAS PHARMA INC (JP) 2012-09-19 EP disclosed
US-8207199-B2 Azole compound ASTELLAS PHARMA INC. (JP) 2012-06-26 US disclosed
US-20110118311-A1 AZOLE COMPOUND ASTELLAS PHARMA INC. (JP) 2011-05-19 US disclosed
EP-2308869-A1 AZOLE COMPOUND Astellas Pharma Inc. (JP) 2011-04-13 EP disclosed
WO-2010007966-A1 AZOLE COMPOUND アステラス製薬株式会社 (JP) 2010-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118311-A1 AZOLE COMPOUND FAAH, FAAH2, TRPV1 HSD11B1 2752/4885HRH3 52/4885GPR142 716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.